2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting

2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting is organized by Consortium of Multiple Sclerosis Centers (CMSC) and will be held from May 28 - 31, 2025 at Phoenix Convention Center, Phoenix, Arizona, United States of America.

Track Learning Objectives:
The Continuing Education Committee has identified educational gaps in ten content areas and has invited noted faculty to develop and conduct educational sessions in each of the following learning tracks.

MS Management (MG)

• Examine the various models of care in MS and the roles and responsibilities of care team members in order to support the provision of team-based, comprehensive care via the most appropriate model for a given practice setting which allows for the provision of evidence-based MS care.
• Summarize methods to monitor treatment outcomes including patient self-report, automated self-assessment, clinician reported outcomes, imaging, and biomarkers in order to optimize their utilization in clinical practice and research.

Mental Health (MH)

• Conduct a thorough patient assessment that allows for differentiation between mental health, psychosocial, and cognitive issues in MS.
• Incorporate information obtained through appropriate assessments into therapeutic plans of care for each identified area of concern.
• Develop appropriate strategies for treatment and ongoing monitoring of changes affecting quality of life.
• Identify professional and community resources that support the work of the mental health team in providing comprehensive care to patients with MS.

Nursing (RN)

• Evaluate current nursing practice in various models of care utilized to implement individualized interventions and monitor outcomes in the care of patients with MS.
• Incorporate specific and evidence-based nursing skills into the development of team-based plans for individualized care of patients and families affected by MS.

Professionalism, Ethics, Advocacy (PE)

• Support MS patients and their families as they confront challenges wrought by the disease while protecting the individual’s right to privacy, information, and refusal of treatment.
• Promote and advance the roles of healthcare professionals dedicated to MS care to allow full and appropriate access to needed treatments, programs, and services.
• Represent people with MS to help secure their legal and human rights and empower people with MS to become self-advocates.
• Incorporate acquired information into professional practice skills that enhance comprehensive MS care and better serve patients, families, and colleagues.

Rehabilitation (RH)

• Integrate rehabilitative strategies into the multidisciplinary management of the comorbidities and sequelae of MS to optimize patients’ function and quality of life.
• Identify MS-specific screening techniques that facilitate individualized and targeted rehabilitation services.

Research (RS)

• Synthesize emerging data on treatment strategies and monitoring of safety and efficacy in order to promote continuing insights into disease pathology, course, and management.
• Review the design and outcomes of clinical trials in relapsing and progressive forms of MS and disseminate this information to prepare clinicians to evaluate trial quality and, where appropriate, integrate findings into clinical practice.

Science of MS (SC)

• Review the current understanding of diagnostic criteria, phenotypes, and variants of MS to promote accurate diagnosis, initiation of appropriate therapy and monitoring of outcomes.
• Identify the roles and interactions of genetics and epigenetics, the microbiome, environmental factors, age, comorbidities, and risk behaviors as factors contributing to pathogenesis and the course of MS.

Pharmacologic and Symptomatic Management (PS)

• Identify assessment techniques to isolate those factors that affect the manifestation of the complex symptomatology of MS and differentiate between acute and chronic MS symptoms.
• Analyze common symptoms of MS and their appropriate pharmacologic and non-pharmacologic interventions in order to develop strategies designed to maximize function and quality of life.

Technologic Advances (TC)

• Examine innovations in diagnostic, rehabilitative, adaptive, communication, and educational technology that have an impact on the care of patients with MS throughout the spectrum of the disease.
• Incorporate technology appropriately to enhance care and research in MS.

Wellness (WE)

• Recognize the importance of focusing on wellness outcomes and incorporate this perspective into all of MS clinical care and patient and family education.
• Integrate wellness concepts into long-term planning as the patient condition changes to optimize wellness strategies at all stages of disease.